Filovirus-induced Endothelial Leakage Triggered by Infected Monocytes/macrophages
Overview
Affiliations
The pathogenetic mechanisms underlying hemorrhagic fevers are not fully understood, but hemorrhage, activation of coagulation, and shock suggest vascular instability. Here, we demonstrate that Marburg virus (MBG), a filovirus causing a severe form of hemorrhagic fever in humans, replicates in human monocytes/macrophages, resulting in cytolytic infection and release of infectious virus particles. Replication also led to intracellular budding and accumulation of viral particles in vacuoles, thus providing a mechanism by which the virus may escape immune surveillance. Monocytes/macrophages were activated by MBG infection as indicated by tumor necrosis factor alpha (TNF-alpha) release. Supernatants of monocyte/macrophage cultures infected with MBG increased the permeability of cultured human endothelial cell monolayers. The increase in endothelial permeability correlated with the time course of TNF-alpha release and was inhibited by a TNF-alpha specific monoclonal antibody. Furthermore, recombinant TNF-alpha added at concentrations present in supernatants of virus-infected macrophage cultures increased endothelial permeability in the presence of 10 micron H2O2. These results indicate that TNF-alpha plays a critical role in mediating increased permeability, which was identified as a paraendothelial route shown by formation of interendothelial gaps. The combination of viral replication in endothelial cells (H.-J. Schnittler, F. Mahner, D. Drenckhahn, H.-D. Klenk, and H. Feldmann, J. Clin. Invest. 19:1301-1309, 1993) and monocytes/macrophages and the permeability-increasing effect of virus-induced cytokine release provide the first experimental data for a novel concept in the pathogenesis of viral hemorrhagic fever.
Sorvillo T, Ritter J, Welch S, Coleman-McCray J, Davies K, Hayes H Emerg Microbes Infect. 2024; 13(1):2427782.
PMID: 39513496 PMC: 11578417. DOI: 10.1080/22221751.2024.2427782.
Vascular dysfunction in hemorrhagic viral fevers: opportunities for organotypic modeling.
Zarate-Sanchez E, George S, L Moya M, Robertson C Biofabrication. 2024; 16(3).
PMID: 38749416 PMC: 11151171. DOI: 10.1088/1758-5090/ad4c0b.
Entry inhibitors as arenavirus antivirals.
Iyer K, Yan Z, Ross S Front Microbiol. 2024; 15:1382953.
PMID: 38650890 PMC: 11033450. DOI: 10.3389/fmicb.2024.1382953.
Mane Manohar M, Lee V, Chinedum Odunukwe E, Singh P, Mpofu B, Oxley Md C Cureus. 2023; 15(7):e42014.
PMID: 37593293 PMC: 10430785. DOI: 10.7759/cureus.42014.
Immune correlates of protection for SARS-CoV-2, Ebola and Nipah virus infection.
Escudero-Perez B, Lawrence P, Castillo-Olivares J Front Immunol. 2023; 14:1156758.
PMID: 37153606 PMC: 10158532. DOI: 10.3389/fimmu.2023.1156758.